Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
View corresponding page on italian website CURASEPT.IT
Home
Steps

The milestones of these 25 years

Every growth story is made up of steps, insights and people who believe in a project.

Ours began in 2001 with an innovative drive, and we haven’t stopped since.

From the first ADS patent to international expansion, from the research that gave rise to our iconic lines to the most recent innovations, each chapter has contributed to building the Curasept of today: a brand that combines science, vision and care.

2026 is the year in which we will celebrate this 25-year journey.

An important milestone, but above all a starting point for continuing to innovate and improve people’s oral health.

2001 - A company is founded with an innovative, “out-of-the-box” spirit, placing care for the individual at its core.
Care for people - Global community - Regeneration
2002 - The ADS system and the first patent. A product enters the market that will revolutionize patient compliance.
2005 - Curasept becomes the LEADER IN THE CHLORHEXIDINE MARKET in pharmacies.
R&D - Prestigious collaborations with universities and research centers, with 10% of annual turnover invested in Research & Development. 11 patents and more than 100 studies and clinical cases.
MISSION - We stand by people with the most original, innovative, and high-quality solutions in the field of oral health.
The first certifications: in 2007 ISO 9001, in 2010 ISO 13485, and in 2009 the first certification of our Class III medical devices.
2012 - The first COMBINATION CHLORHEXIDINE products are introduced alongside the CURASEPT ADS line.
CERTIFICATIONS - The certifications obtained by Curasept S.p.A. testify to our commitment to excellence.
NUMBERS - People: Over 300 people. Dental Practices: More than 30,000 dental practices. Pharmacy Presence: 99% of pharmacies in Italy.
2012 - The first COMBINATION CHLORHEXIDINE products are introduced alongside the CURASEPT ADS line.
2017 - Curasept expands its value proposition by also offering tools for Mechanical Oral Hygiene.
COMMITMENT TO PREVENTION - Educational activities in schools and across media. Participation in over 100 industry conferences and trade fairs. More than 500,000 samples distributed.
2018 - Entry into international markets: Curasept is now present on 4 continents.
2020 The ADS system is further enhanced with the addition of polynucleotides: CURASEPT ADS | DNA is born, later integrated with NAC in 2023.
2022 - Curasept launches Curasept Protection Booster and Curasept Prevent, products also focused on primary and secondary prevention.
25 YEARS FOR ORAL HEALTH. WITH CARE.
Discover the meaning behind the 25th anniversary logo

THE FIRST NON-STAINING CHLORHEXIDINE

The first Curasept mouthwashes and toothpastes with Chlorhexidine featuring A.D.S.® – Anti Discoloration System, an innovative, patented, and clinically tested system that reduces the appearance of yellow-brown spots on the teeth, which is the main side effect of Chlorhexidine.

A.D.S.® inhibits the two chemical reactions leading to pigmentation, without affecting the antiplaque activity of Chlorhexidine. 

Curasept ADS

punto elenco blu e azzurro, nei colori inconfondibili del brand Curasept

Vuoi accedere ai contenuti Extra? Registrati o fai Login per accedere ai contenuti a te dedicati: articoli, video ,schede… e tanto altro!

Non ricordi la password?

Non sei registrato?
Clicca il pulsante qui sotto. La registrazione è gratuita.

Registrazione

Quality Policy

The Quality for CURASEPT S.p.A. is an essential condition to put itself successfully on the market, considering its characteristics and evolution.

The development of the Company and its profit are insured by the continuous search for quality towards excellence through the continuous improvement of its processes and the search for partners with quality systems adapted to our standards.

The Company aims to increase the customer satisfaction through the application of its Quality Management System, including the processes to improve the system and to ensure the compliance with the customer and applicable regulatory requirements.

For this purpose, the Company performs specific risks and opportunities assessment activities, connected to the context, stakeholders and related objectives, in order to identify the areas of system improvements and to define the appropriate actions for the risk control and mitigation and strengthening of its Quality System.

The starting point for the implementation of this policy is the pursuit of the following objectives:

  • Define and implement a Quality Management System according to 9001:2015+A1:2024 e UNI CEI EN ISO 13485:2021 regulation, as Manufacturer of Medical Devices;
  • Define and implement a system of procedures and operating instructions in harmony with the Directive 93/42/CEE, the Regulation (UE) 2017/745 and the Regulation (UE) 2023/607 for the applicable parts and subsequent changes and integrations, which satisfy the essential requirements set out in Annex I;
  • Define and implement a system of procedures in harmony with the Directive 2010/84, the Regulation 1235/2010, the Implementation Regulation n. 520/2012 and in accordance with the objectives of “module I – “Good Vigilance Practices” (GVP).
  • Define and implement, in collaboration with Outsourcers, a quality system and procedures to meet the regulatory requirements for the production of Cosmetics and Food Supplements.
  • Establish and formalize the business organizational structure with the subdivision into areas of competences;
  • Clarify roles and responsibilities of business functions;
  • Define strategies and objectives and assign human and material resources for their achievement;
  • Define accurately business processes and related performance factors;
  • Ensure compliance with qualitative, quantitative and temporal requirements;
  • Constantly monitor the level of adequacy of the system with reference to regulations and laws;
  • Promote initiatives in order to improve the process of motivational and professional growth of human resources, considered as critical resources for future business developments;
  • Ensure the commitment to the satisfaction of requirements and the maintenance of effectiveness of the Quality Management System.

These objectives can be realized thanks to the involvement of the whole Company personnel.

In particular, the Managers of each Function provide their contribution so that the suggested improvements can be proposed to the General Direction, so that the Quality Policy can be a priority element in the choice of business qualitative and organizational strategies.

The involvement of the whole personnel in the improvement of internal and external processes should be aimed at reducing non-compliance and internal and external costs of non-quality; for this reason all employees should feel themselves committed in pursuing this policy.

Training courses, for all business levels, are promoted and planned by the General Direction in order to keep the personnel constantly up to date on the improvements performed for the processes.

The Quality Manual, which is distributed via the SistemaQualità to all process managers and the General Director, should represent a work tool for all Managers and their personnel for the implementation of the Quality Policy.

May 2026

General Direction